COVID-19 And The Future Of Rx Pricing Policy: An Interview With White House Advisor Grogan
Executive Summary
White House Domestic Policy Council Director Joe Grogan is departing at the end of May. In an interview, he talked about lessons (so far) from the COVID-19 response and the future of drug pricing policy against the backdrop of the pandemic.
You may also be interested in...
BIO 2020 Notebook: Conversations On Rebates, Racism And Remote Working
News and views from day four of BIO Digital also include discussion of whether the pandemic is discouraging mega mergers.
BIO 2020 Notebook: Conversations On Rebates, Racism, And Remote Working
News and views from day four of BIO Digital also include discussion of whether the pandemic is discouraging mega mergers.
White House Wants To Avoid Fight On Rebates, Get Quick Passage Of Senate Rx Pricing Bill
“We’re out of time for ideas," Domestic Policy Council Director Joe Grogan says. Trump administration is pushing hard to get the Senate drug pricing bill through Congress quickly and score a major victory for the President.